Literature DB >> 6231306

Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.

L F Brass, S J Shattil.   

Abstract

Extracellular Ca2+ is required for platelet aggregation and secretion in response to ADP or epinephrine. Recently, we reported that the platelet surface contains two classes of high affinity binding sites for extracellular Ca2+. To identify these sites and clarify their role in platelet function, we have now (a) studied platelets congenitally deficient in surface membrane glycoproteins and (b) examined the effect of removing surface-bound Ca2+ on platelet responses to ADP and epinephrine. Unstimulated normal platelets contained 86,000 Ca2+-binding sites/platelet with a dissociation constant (Kd) of 9 nM and 389,000 sites with a Kd of 400 nM. In contrast, thrombasthenic platelets, which lack glycoproteins IIb and IIIa, exhibited a 92% reduction in the number of higher affinity Ca2+-binding sites and a 63% reduction in the number of lower affinity sites. Bernard-Soulier platelets, which lack glycoprotein Ib, were not deficient in Ca2+-binding sites. After stimulation with ADP, both normal and thrombasthenic platelets developed approximately 138,000 new Ca2+-binding sites/platelet (Kd = 400 nM), while the larger Bernard-Soulier platelets developed 216,000 new sites. These data suggest that IIb and IIIa represent the major Ca2+-binding glycoproteins on unstimulated platelets, while neither these glycoproteins nor Ib represent the new Ca2+-binding sites on stimulated platelets. Removal of Ca2+ from the platelet surface inhibited platelet function. Despite the presence of 1 mM Mg2+, ADP- and epinephrine-induced aggregation and [14C]serotonin release were markedly decreased at free Ca2+ concentrations less than 7 nM, a value similar to the Kd of the higher affinity Ca2+-binding sites. Moreover, gadolinium, a lanthanide that competed for these Ca2+-binding sites, also inhibited aggregation and serotonin release. These studies demonstrate, therefore, that the binding of extracellular Ca2+ to glycoproteins IIb/IIIa on unstimulated platelets or to additional membrane proteins on stimulated platelets is necessary for maximal platelet responses to ADP and epinephrine. Thus, the requirement for extracellular Ca2+ during platelet activation by these agonists may actually represent a requirement for surface-bound Ca2+.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231306      PMCID: PMC425061          DOI: 10.1172/JCI111252

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Divalent cation requirements for aggregation of human blood platelets and the role of the anti-coagulant.

Authors:  M C Scrutton; C M Egan
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

Review 2.  The informational role of calcium in the cytosol.

Authors:  R H Kretsinger
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

3.  Gel filtration. A new technique for separation of blood platelets from plasma.

Authors:  O Tangen; H J Berman; P Marfey
Journal:  Thromb Diath Haemorrh       Date:  1971-06-30

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets.

Authors:  P N Walsh; D C Mills; F I Pareti; G J Stewart; D E Macfarlane; M M Johnson; J J Egan
Journal:  Br J Haematol       Date:  1975-04       Impact factor: 6.998

6.  Exposure of platelet fibrinogen receptors by ADP and epinephrine.

Authors:  J S Bennett; G Vilaire
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets.

Authors:  L C Best; E A Bone; P B Jones; R G Russell
Journal:  Biochim Biophys Acta       Date:  1980-10-01

8.  Nonreversible loss of platelet aggregability induced by calcium deprivation.

Authors:  M B Zucker; R A Grant
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

9.  Correlation between fibrinogen binding to human platelets and platelet aggregability.

Authors:  E I Peerschke; M B Zucker; R A Grant; J J Egan; M M Johnson
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

10.  Decreased association of 45calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation.

Authors:  E I Peerschke; R A Grant; M B Zucker
Journal:  Br J Haematol       Date:  1980-10       Impact factor: 6.998

View more
  7 in total

1.  Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature.

Authors:  G A Rivas; J González-Rodríguez
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia.

Authors:  M H Ginsberg; A Lightsey; T J Kunicki; A Kaufmann; G Marguerie; E F Plow
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 3.  Reconstruction of integrin activation.

Authors:  Feng Ye; Chungho Kim; Mark H Ginsberg
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

4.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Calcium and temperature regulation of the stability of the human platelet integrin GPIIb/IIIa in solution: an analytical ultracentrifugation study.

Authors:  G A Rivas; P Usobiaga; J González-Rodriguez
Journal:  Eur Biophys J       Date:  1991       Impact factor: 1.733

6.  A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.

Authors:  A T Nurden; J P Rosa; D Fournier; C Legrand; D Didry; A Parquet; D Pidard
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa.

Authors:  P J Newman; Y Kawai; R R Montgomery; T J Kunicki
Journal:  J Cell Biol       Date:  1986-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.